<bill session="108" type="h" number="2544" updated="2013-07-14T19:01:32-04:00">
  <state datetime="2003-06-19">REFERRED</state>
  <status>
    <introduced datetime="2003-06-19"/>
  </status>
  <introduced datetime="2003-06-19"/>
  <titles>
    <title as="introduced" type="short">Medical Independence, Privacy, and Innovation Act of 2003</title>
    <title as="introduced" type="official">To improve the quality, availability, diversity, personal privacy, and innovation of health care in the United States.</title>
  </titles>
  <sponsor id="400343"/>
  <cosponsors/>
  <actions>
    <action state="REFERRED" datetime="2003-06-19">
      <text>Referred to the Committee on Ways and Means, and in addition to the Committees on Energy and Commerce, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2003-06-19">
      <text>Referred to House Ways and Means</text>
    </action>
    <action datetime="2003-06-19">
      <text>Referred to House Energy and Commerce</text>
    </action>
    <action datetime="2003-06-19">
      <text>Referred to House Judiciary</text>
    </action>
    <action datetime="2003-06-24">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR H5808-5811"/>
    </action>
    <action datetime="2003-06-27">
      <text>Referred to the Subcommittee on Health.</text>
      <committee name="House Ways and Means"/>
    </action>
    <action datetime="2003-07-01">
      <text>Referred to the Subcommittee on Health.</text>
      <committee name="House Energy and Commerce"/>
    </action>
    <action datetime="2003-09-04">
      <text>Referred to the Subcommittee on Courts, the Internet, and Intellectual Property.</text>
      <committee name="House Judiciary"/>
    </action>
  </actions>
  <committees>
    <committee code="HSWM" name="House Ways and Means" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSWM02" subcommittee="Health" name="House Ways and Means"/>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSIF14" subcommittee="Health" name="House Energy and Commerce"/>
    <committee code="HSJU" name="House Judiciary" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSJU03" subcommittee="Courts, the Internet, and Intellectual Property" name="House Judiciary"/>
  </committees>
  <relatedbills>
    <bill relation="unknown" session="108" type="h" number="2196"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Administrative procedure"/>
    <term name="Administrative remedies"/>
    <term name="Bank accounts"/>
    <term name="Civil rights and liberties, minority issues"/>
    <term name="Clinical trials"/>
    <term name="Coinsurance"/>
    <term name="Commerce"/>
    <term name="Crime and law enforcement"/>
    <term name="Criminal justice information"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug approvals"/>
    <term name="Drug industry"/>
    <term name="Drug interactions"/>
    <term name="Drugs"/>
    <term name="Excise tax"/>
    <term name="Executive reorganization"/>
    <term name="Finance and financial sector"/>
    <term name="Foreign trade and international finance"/>
    <term name="Government operations and politics"/>
    <term name="Government paperwork"/>
    <term name="Government property"/>
    <term name="Government publicity"/>
    <term name="Governmental investigations"/>
    <term name="Health insurance"/>
    <term name="Imports"/>
    <term name="Income tax"/>
    <term name="Insurance premiums"/>
    <term name="Intellectual property"/>
    <term name="Inventions"/>
    <term name="Labeling"/>
    <term name="Law"/>
    <term name="Licenses"/>
    <term name="Marketing"/>
    <term name="Medical economics"/>
    <term name="Medical records"/>
    <term name="Medical savings accounts"/>
    <term name="Minorities"/>
    <term name="Minority health"/>
    <term name="Ombudsman"/>
    <term name="Packaging"/>
    <term name="Patent infringement"/>
    <term name="Patents"/>
    <term name="Patient satisfaction"/>
    <term name="Patients' rights"/>
    <term name="Pharmaceutical research"/>
    <term name="Pharmacies"/>
    <term name="Right of privacy"/>
    <term name="Science, technology, communications"/>
    <term name="Tax credits"/>
    <term name="Tax deductions"/>
    <term name="Tax exclusion"/>
    <term name="Tax exemption"/>
    <term name="Tax penalties"/>
    <term name="Taxation"/>
    <term name="Trusts and trustees"/>
    <term name="Wholesale trade"/>
    <term name="Women"/>
    <term name="Women's health"/>
  </subjects>
  <amendments/>
  <summary>6/19/2003--Introduced.
Medical Independence, Privacy, and Innovation Act of 2003 - Amends the Internal Revenue Code to eliminate language making the medical expense deduction only apply to the extent the relevant expenses exceed 7.5 percent of adjusted gross income. Permits the deduction in computing adjusted gross income.Exempts medical checking accounts from being subjected to certain taxes. Subjects such accounts to taxes on unrelated business income of charitable organizations. Allows a deduction equal to the amount paid in cash to an individual's medical checking account (up to $1,000, or $2,000 in the case of a joint return) and a credit (of up to $1,000) for contributions made to such account.Excludes from gross income any amount paid or distributed out of a medical checking account which is used exclusively to pay qualified medical expenses of any account holder.Decreases the minimum annual deductibles under a high deductible health plan for purposes of Archer medical savings accounts.Makes modifications to regulations regarding the privacy of individually identifiable health information.Prohibits the granting of an exclusive or partially exclusive license regarding an invention made with Federal assistance, except in accordance with specified provisions of Federal law pertaining to the licensing of Federally owned inventions.Amends the Federal Food, Drug, and Cosmetic Act to direct the Secretary to promulgate regulations permitting pharmacists and wholesalers to import prescription drugs from foreign nations, with such regulations to require that each such drug complies with sections of the Act pertaining to new drugs, adulterated drugs and devices, and misbranded drugs and devices, and with other applicable requirements of this Act. (Current law directs the Secretary to promulgate regulations permitting pharmacists and wholesalers to import prescription drugs, except for specified controlled substances and biological products).</summary>
</bill>
